临床肝胆病杂志2025，Vol.41Issue(8)：1517-1520,4.DOI:10.12449/JCH250808
《2025年欧洲肝病学会临床实践指南:肝外胆管癌的管理》摘译
An excerpt of EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma(2025)
丁宗仁 1黄尧 1曾永毅1
作者信息
- 1. 福建医科大学孟超肝胆医院肝胆外科,福州 350025
- 折叠
摘要
Abstract
In recent years,significant progress has been made in the radiological diagnosis,molecular profiling,and systemic therapy of cholangiocarcinoma(CCA).Nevertheless,there are still many challenges in early identification,precise classification,and effective management.Given the marked heterogeneity between CCA subtypes and the recent research advances,the European Association for the Study of the Liver has developed evidence-based management recommendations for extrahepatic CCA,covering both perihilar and distal subtypes.This guideline particularly emphasizes the need for precise classification systems,the integration of emerging molecular studies,and practical diagnostic and therapeutic strategies reflecting real-world clinical scenarios.关键词
胆管肿瘤/欧洲/诊疗准则Key words
Bile Duct Neoplasms/Europe/Practice Guidelines引用本文复制引用
丁宗仁,黄尧,曾永毅..《2025年欧洲肝病学会临床实践指南:肝外胆管癌的管理》摘译[J].临床肝胆病杂志,2025,41(8):1517-1520,4.
